Cancer persister cells

Forums General Melanoma Community Cancer persister cells

  • Post
    lou2
    Participant

      Don't know for sure if this applies to melanoma, but can't see why it wouldn't.

       

      Cancer Persister Cells

      Similar to the obstacle in treatment of patients that develop resistance to antimicrobials, acquisition of resistance to anticancer drugs is a major problem in cancer therapy. Most treatments, even ones that work, fail over time because tumor cells become resistant. Different mechanisms of resistance have been described for cancer cells such as modification of drug target and active extrusion of drugs by efflux pumps and, therefore, it was largely assumed that random gene changes confer resistance to drugs [19]. However, this does not explain an increasingly observed phenomenon in cancer chemotherapy; “retreatment response” [20], [21]. In this model, it is proposed that once a small number of cells that survive exposure to drugs that killed the majority of the cells are given a “drug holiday,” they eventually regain their sensitivity to the drug [22]. These observations indicate that acquired resistance to cancer drugs may not necessarily result from stable genetic mutations but may also involve a reversible “drug-tolerant” state [22], [23].

      from this article:

      http://tiny.cc/meep7w

      (Mostly about anti-microbials, but the above paragraph on cancer seemed very intriguing)

    Viewing 2 reply threads
    • Replies
        lou2
        Participant

          But maybe not applying to the drugs that target mutations, because it may be that multiple mutations are involved at the outset.  So the "resistance" may be that the original target has been hit, with the remaining cells of a different mutation type.  Then a repeat of the the same drug later may fail for this reason.

          ???????

          lou2
          Participant

            But maybe not applying to the drugs that target mutations, because it may be that multiple mutations are involved at the outset.  So the "resistance" may be that the original target has been hit, with the remaining cells of a different mutation type.  Then a repeat of the the same drug later may fail for this reason.

            ???????

            lou2
            Participant

              But maybe not applying to the drugs that target mutations, because it may be that multiple mutations are involved at the outset.  So the "resistance" may be that the original target has been hit, with the remaining cells of a different mutation type.  Then a repeat of the the same drug later may fail for this reason.

              ???????

          Viewing 2 reply threads
          • You must be logged in to reply to this topic.
          About the MRF Patient Forum

          The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

          The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

          Popular Topics